Cargando…

Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy

Renal cell carcinoma (RCC) is a type of cancer with an increasing rate of morbidity and mortality and is a serious threat to human health. The treatment of RCC, especially kidney renal clear cell carcinoma (KIRC), has always been the focus of clinical treatment. Using The Cancer Genome Atlas (TCGA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Xiaochen, Che, Xiangyu, Li, Quanlin, Wang, Qifei, Wu, Guangzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252305/ https://www.ncbi.nlm.nih.gov/pubmed/35795559 http://dx.doi.org/10.3389/fphar.2022.918647

Ejemplares similares

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
por: Qi, Xiaochen, et al.
Publicado: (2021)

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target
por: Wu, Guangzhen, et al.
Publicado: (2021)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
por: Wang, Jin, et al.
Publicado: (2022)

Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction
por: Che, Xiangyu, et al.
Publicado: (2021)

The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma
por: Wang, Qifei, et al.
Publicado: (2023)

Potential value of mitochondrial regulatory pathways in the clinical application of clear cell renal cell carcinoma: a machine learning-based study
por: Qi, Xiaochen, et al.
Publicado: (2023)

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration
por: Wu, Guangzhen, et al.
Publicado: (2020)

Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway
por: Che, Xiangyu, et al.
Publicado: (2022)

A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma
por: GE, WENFEI, et al.
Publicado: (2023)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Yonghao, et al.
Publicado: (2022)

A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Qi, Xiaochen, et al.
Publicado: (2021)

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Su, Ganglin, et al.
Publicado: (2021)

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N(6)-Methyladenosine RNA Methylation Regulators
por: Zhang, Yan, et al.
Publicado: (2021)

PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
por: Zhao, Bin, et al.
Publicado: (2018)

Correction to: PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
por: Zhao, Bin, et al.
Publicado: (2021)

Comprehensive Analysis of the Immune Infiltrates of Pyroptosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2021)

A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma
por: Zhang, Minhao, et al.
Publicado: (2023)

Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications
por: Sun, Jiaao, et al.
Publicado: (2023)

Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma
por: Wang, Ganggang, et al.
Publicado: (2022)

Pyroptosis-related genes prognostic model for predicting targeted therapy and immunotherapy response in soft tissue sarcoma
por: Liu, Mengmeng, et al.
Publicado: (2023)

Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
por: Wang, Mei-Zi, et al.
Publicado: (2022)

Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles
por: Huang, Qi, et al.
Publicado: (2023)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
por: Porta, Camillo, et al.
Publicado: (2017)

Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
por: Zhu, Jianshu, et al.
Publicado: (2023)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma
por: Liu, An, et al.
Publicado: (2022)

Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019)

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro
por: Jia, Qi, et al.
Publicado: (2022)

Development and validation of a kidney renal clear cell carcinoma prognostic model relying on pyroptosis-related LncRNAs-A multidimensional comprehensive bioinformatics exploration
por: Liu, Chang, et al.
Publicado: (2023)

Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment
por: Lin, Gaoteng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jful0eebvvbtn3r0sml43tptiu